Tirzepatide Linked to Suspected Biphasic Anaphylaxis in Case Report
A 37-year-old woman experienced suspected biphasic anaphylaxis after her first known subcutaneous dose of tirzepatide, according to a case report published by Cureus. The patient required emergency treatment for respiratory and cardiovascular distress, followed by a second reaction an hour later, highlighting the potential for severe hypersensitivity reactions to the dual GIP and GLP-1 receptor … Read more